Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials.
Zhuang, Xiao-Dong
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials. [electronic resource] - Cardiovascular diabetology 06 2018 - 79 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
1475-2840
10.1186/s12933-018-0722-z doi
Cardiovascular Diseases--chemically induced
Diabetes Mellitus, Type 2--diagnosis
Humans
Hypoglycemia--chemically induced
Hypoglycemic Agents--adverse effects
Protective Factors
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Treatment Outcome
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials. [electronic resource] - Cardiovascular diabetology 06 2018 - 79 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
1475-2840
10.1186/s12933-018-0722-z doi
Cardiovascular Diseases--chemically induced
Diabetes Mellitus, Type 2--diagnosis
Humans
Hypoglycemia--chemically induced
Hypoglycemic Agents--adverse effects
Protective Factors
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Treatment Outcome